CN101049441A - Capsule for treating aplastic anemia, and producing method - Google Patents
Capsule for treating aplastic anemia, and producing method Download PDFInfo
- Publication number
- CN101049441A CN101049441A CNA2007101062397A CN200710106239A CN101049441A CN 101049441 A CN101049441 A CN 101049441A CN A2007101062397 A CNA2007101062397 A CN A2007101062397A CN 200710106239 A CN200710106239 A CN 200710106239A CN 101049441 A CN101049441 A CN 101049441A
- Authority
- CN
- China
- Prior art keywords
- radix
- capsule
- raw material
- cortex moutan
- poria
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Abstract
A Chinese medicine in the form of capsule for treating aplastic anemia is prepared from 20 Chinese-medicinal materials including pilose asiabell root, astragalus root, Chinese angelica rot, coix seed, etc. Its preparing process is also disclosed.
Description
One, technical field:
The present invention relates to a kind of capsule and production method thereof, particularly a kind of capsule and production method thereof for the treatment of aplastic anemia.
Two, background technology:
At present, treatment aplastic anemia does not have any specific medicament, generally can not cure, and just earns a bare living.
Three, summary of the invention:
The objective of the invention is to invent a kind of capsule and production method thereof for the treatment of aplastic anemia, this capsule formula uniqueness, materials science, fastidious.Simple and practical production method.The medicine of producing has better curative effect for treatment aplastic anemia, by clinical practice, is taking this capsule after nine courses of treatment, and cure rate can reach 97%, and effective percentage can reach 100%.
Purpose of the present invention can realize by following embodiment: the weight portion of this capsule raw material is: Radix Codonopsis 25～35, the Radix Astragali 25～35, Rhizoma Polygonati 15～25, Radix Angelicae Sinensis 5～15, Semen Coicis 25～35, Herba Taxilli 10～20, Poria 7～17, the Radix Rehmanniae 10～20, Radix Rehmanniae Preparata 10～20, the Radix Paeoniae Alba 10～20, Endothelium Corneum Gigeriae Galli 1～10, charred CORTEX MOUTAN 2～11, mountain mast 5～15, Rhizoma Imperatae 25～35, Radix Scrophulariae 15～25, Radix Arnebiae (Radix Lithospermi) 15～25, Radix Rubiae 7～17, river Cortex cinnamomi japonici (Ramulus Cinnamomi) 2～11, Radix Dipsaci 10～20, Cornu Bubali 5～15.
This capsular production method is: A, pure processing, and the raw material that chooses according to the above ratio removes dust, impurity and non-medicinal part; B, charred CORTEX MOUTAN are manufactured, and Cortex Moutan is fried the property retained to turning black with marmite; C, medicine concentrate, according to the above ratio medicine is put into marmite, add tap water and cover medicine, dense frying in shallow oil 30～50 minutes, thereafter the liquid after dense the frying in shallow oil is put into and carries out dry in the sun on the card that corrosion resistant plate makes and become dried piece: D, become 7 of dried piece not have the ratio of fried raw material 3 to carry out pulverization process, cross 120 mesh sieves then in dry in the sun; E, the powder after will sieving are canned with " 0 " number medical capsule.
Advantage of the present invention is: prescription is unique, materials science, fastidious.Simple and practical production method.The medicine of producing has better curative effect for treatment aplastic anemia, by clinical practice, taking this capsule after nine courses of treatment, cure rate can reach 97%, effective percentage can reach 100%, is a kind of capsule and production method thereof of ideal treatment aplastic anemia.
Four, the specific embodiment:
Be 3 embodiment of parts by weight of raw materials of the present invention below:
1, the weight portion of raw material is: Radix Codonopsis 25, the Radix Astragali 25, Rhizoma Polygonati 15, Radix Angelicae Sinensis 5, Semen Coicis 25, Herba Taxilli 10, Poria 7, the Radix Rehmanniae 10, Radix Rehmanniae Preparata 10, the Radix Paeoniae Alba 10, Endothelium Corneum Gigeriae Galli 1, charred CORTEX MOUTAN 2, mountain mast 5, Rhizoma Imperatae 25, Radix Scrophulariae 15, Radix Arnebiae (Radix Lithospermi) 15, Radix Rubiae 7, river Cortex cinnamomi japonici (Ramulus Cinnamomi) 2, Radix Dipsaci 10, Cornu Bubali 5.
2, the weight portion of raw material is: Radix Codonopsis 30, the Radix Astragali 30, Rhizoma Polygonati 20, Radix Angelicae Sinensis 10, Semen Coicis 30, Herba Taxilli 15, Poria 12, the Radix Rehmanniae 15, Radix Rehmanniae Preparata 15, the Radix Paeoniae Alba 15, Endothelium Corneum Gigeriae Galli 5, charred CORTEX MOUTAN 6, mountain mast 10, Rhizoma Imperatae 30, Radix Scrophulariae 20, Radix Arnebiae (Radix Lithospermi) 20, Radix Rubiae 12, river Cortex cinnamomi japonici (Ramulus Cinnamomi) 6, Radix Dipsaci 15, Cornu Bubali 10.
3, the weight portion of raw material is: Radix Codonopsis 35, the Radix Astragali 35, Rhizoma Polygonati 25, Radix Angelicae Sinensis 15, Semen Coicis 35, Herba Taxilli 20, Poria 17, the Radix Rehmanniae 20, Radix Rehmanniae Preparata 20, the Radix Paeoniae Alba 20, Endothelium Corneum Gigeriae Galli 10, charred CORTEX MOUTAN 11, mountain mast 15, Rhizoma Imperatae 35, Radix Scrophulariae 25, Radix Arnebiae (Radix Lithospermi) 25, Radix Rubiae 17, river Cortex cinnamomi japonici (Ramulus Cinnamomi) 11, Radix Dipsaci 20, Cornu Bubali 15.
The production method of the embodiment of the invention is with the scheme part.
Capsule of the present invention is a pure Chinese medicine capsule, the composition that invigorating the spleen and benefiting QI, heat-clearing and toxic substances removing, promotion of blood circulation, benefiting qi and removing blood stasis, nourishing the liver and kidney, passage, nourishing blood, temperature compensation QI and blood are arranged in it, the focus of can going directly, took effect in oral 1 month for treatment aplastic anemia, various hemocytees recovered normal range substantially in 2～5 months, 9 months hemoglobin, platelet, the equal clinical recovery of leukocyte.4～6 courses of treatment of consolidation, take non-relapse after healing at interval.
Claims (5)
1, a kind of capsule for the treatment of aplastic anemia is characterized in that the weight portion of its raw material is: Radix Codonopsis 25～35, the Radix Astragali 25～35, Rhizoma Polygonati 15～25, Radix Angelicae Sinensis 5～15, Semen Coicis 25～35, Herba Taxilli 10～20, Poria 7～17, the Radix Rehmanniae 10～20, Radix Rehmanniae Preparata 10～20, the Radix Paeoniae Alba 10～20, Endothelium Corneum Gigeriae Galli 1～10, charred CORTEX MOUTAN 2～11, mountain mast 5～15, Rhizoma Imperatae 25～35, Radix Scrophulariae 15～25, Radix Arnebiae (Radix Lithospermi) 15～25, Radix Rubiae 7～17, river Cortex cinnamomi japonici (Ramulus Cinnamomi) 2～11, Radix Dipsaci 10～20, Cornu Bubali 5～15.
2, capsule according to claim 1 is characterized in that the weight portion of its raw material is: Radix Codonopsis 25, the Radix Astragali 25, Rhizoma Polygonati 15, Radix Angelicae Sinensis 5, Semen Coicis 25, Herba Taxilli 10, Poria 7, the Radix Rehmanniae 10, Radix Rehmanniae Preparata 10, the Radix Paeoniae Alba 10, Endothelium Corneum Gigeriae Galli 1, charred CORTEX MOUTAN 2, mountain mast 5, Rhizoma Imperatae 25, Radix Scrophulariae 15, Radix Arnebiae (Radix Lithospermi) 15, Radix Rubiae 7, river Cortex cinnamomi japonici (Ramulus Cinnamomi) 2, Radix Dipsaci 10, Cornu Bubali 5.
3, capsule according to claim 1 is characterized in that the weight portion of its raw material is: Radix Codonopsis 30, the Radix Astragali 30, Rhizoma Polygonati 20, Radix Angelicae Sinensis 10, Semen Coicis 30, Herba Taxilli 15, Poria 12, the Radix Rehmanniae 15, Radix Rehmanniae Preparata 15, the Radix Paeoniae Alba 15, Endothelium Corneum Gigeriae Galli 5, charred CORTEX MOUTAN 6, mountain mast 10, Rhizoma Imperatae 30, Radix Scrophulariae 20, Radix Arnebiae (Radix Lithospermi) 20, Radix Rubiae 12, river Cortex cinnamomi japonici (Ramulus Cinnamomi) 6, Radix Dipsaci 15, Cornu Bubali 10.
4, capsule according to claim 1 is characterized in that the weight portion of its raw material is: Radix Codonopsis 35, the Radix Astragali 35, Rhizoma Polygonati 25, Radix Angelicae Sinensis 15, Semen Coicis 35, Herba Taxilli 20, Poria 17, the Radix Rehmanniae 20, Radix Rehmanniae Preparata 20, the Radix Paeoniae Alba 20, Endothelium Corneum Gigeriae Galli 10, charred CORTEX MOUTAN 11, mountain mast 15, Rhizoma Imperatae 35, Radix Scrophulariae 25, Radix Arnebiae (Radix Lithospermi) 25, Radix Rubiae 17, river Cortex cinnamomi japonici (Ramulus Cinnamomi) 11, Radix Dipsaci 20, Cornu Bubali 15.
5, a kind of as the described capsular production method of each claim of claim 1～4, it is characterized in that:
A, pure processing, the raw material that chooses according to the above ratio removes dust, impurity and non-medicinal part;
B, charred CORTEX MOUTAN are manufactured, and Cortex Moutan is fried the property retained to turning black with marmite;
C, medicine concentrate, and according to the above ratio medicine are put into marmite, add tap water and cover medicine, and dense frying in shallow oil 30～50 minutes is put into the liquid after dense the frying in shallow oil thereafter and carries out dry in the sun on the card that corrosion resistant plate makes and become dried piece;
D, become 7 of dried piece not have the ratio of fried raw material 3 to carry out pulverization process, cross 120 mesh sieves then in dry in the sun;
E, the powder after will sieving are canned with " 0 " number medical capsule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2007101062397A CN101049441A (en) | 2007-05-12 | 2007-05-12 | Capsule for treating aplastic anemia, and producing method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2007101062397A CN101049441A (en) | 2007-05-12 | 2007-05-12 | Capsule for treating aplastic anemia, and producing method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101049441A true CN101049441A (en) | 2007-10-10 |
Family
ID=38781177
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2007101062397A Pending CN101049441A (en) | 2007-05-12 | 2007-05-12 | Capsule for treating aplastic anemia, and producing method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101049441A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103520533A (en) * | 2013-09-24 | 2014-01-22 | 许永喜 | Traditional Chinese medicine for aplastic anemia |
| CN103550507A (en) * | 2013-10-31 | 2014-02-05 | 王运邵 | Traditional Chinese medicine for treating leukemia |
| CN104524255A (en) * | 2014-12-08 | 2015-04-22 | 吕凤荣 | Medicament for treatment of "aplastic anemia" combined gum bleeding illness and preparation method |
-
2007
- 2007-05-12 CN CNA2007101062397A patent/CN101049441A/en active Pending
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103520533A (en) * | 2013-09-24 | 2014-01-22 | 许永喜 | Traditional Chinese medicine for aplastic anemia |
| CN103520533B (en) * | 2013-09-24 | 2016-06-22 | 许永喜 | Chinese medicine for aplastic anemia |
| CN103550507A (en) * | 2013-10-31 | 2014-02-05 | 王运邵 | Traditional Chinese medicine for treating leukemia |
| CN104524255A (en) * | 2014-12-08 | 2015-04-22 | 吕凤荣 | Medicament for treatment of "aplastic anemia" combined gum bleeding illness and preparation method |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101422530A (en) | Traditional Chinese medicine for treating upper right front-tooth pyretic toothache | |
| CN101049441A (en) | Capsule for treating aplastic anemia, and producing method | |
| CN101703742B (en) | Preparation method of granules for treating acne caused by qi deficiency causing blood stasis and phlegm-heat stagnation | |
| CN101366903B (en) | Traditional Chinese medicine composition for treating climacteric syndrome | |
| CN101152282A (en) | Traditional Chinese medicine for treating tumefaction of membrum superius after mammary cancer operation | |
| CN1159037C (en) | Medicine for treating apoplexy | |
| CN104623579A (en) | Traditional Chinese medicine composition for treating uremia | |
| CN1260983A (en) | Process for preparing leukemia medicines | |
| CN103768231A (en) | New purpose of pharmaceutical composition with qi tonifying and blood circulation invigorating effects | |
| CN1298362C (en) | Compound Chinese medicine prepn for treating pulvic infection and its prepn process | |
| CN1125617A (en) | Medicine for treatment of aplastic anemia and its preparation method | |
| CN1686227A (en) | Menstruation regulating powder | |
| CN102872348A (en) | Formula of traditional Chinese medicine for treating shaking palsy caused by qi and blood deficiency | |
| CN101745080A (en) | Chinese patent medicine for treating leukemia | |
| CN102106951A (en) | Chinese medicinal preparation for treating glaucoma | |
| CN1261130C (en) | Medicine for dispelling tinea | |
| CN1111045C (en) | Chewing medicine for treating facial paralysis and its preparing process | |
| CN1425456A (en) | Nourishing wine for regulating human body balance function | |
| CN1207025C (en) | Haidan medicine for treating cardiac and cerebral vascular diseases and its prepn | |
| CN1194733C (en) | Medicine for treating hyperthyroidism and its prepn | |
| CN101757422A (en) | Chinese herbal preparation for treating alopecia areata and seborrheic alopecia | |
| CN1907397A (en) | Decoction preparation for treating QIYINLIANGXU type obstinate eczema and its preparation process | |
| CN1325105C (en) | Oral liquid for clearing liver and gallbladder | |
| CN1066341C (en) | Chinese medicine for treating hepatitis B and preparing process thereof | |
| CN1907419A (en) | Decoction preparation for treating xuezaoshengfeng type skin eczema and its preparation process |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20071010 |